Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 7
1992 32
1993 40
1994 23
1995 19
1996 21
1997 20
1998 53
1999 127
2000 181
2001 322
2002 412
2003 523
2004 757
2005 1091
2006 1430
2007 1884
2008 2380
2009 2856
2010 3323
2011 3790
2012 4218
2013 4455
2014 4511
2015 2758
2016 2250
2017 2689
2018 3038
2019 3663
2020 4817
2021 4979
2022 3656
2023 2143
2024 2262

Search Results

56,297 results

Results by year

Filters applied: . Clear all
Page 1
Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.
Resa-Infante P, Erkizia I, Muñiz-Trabudua X, Linty F, Bentlage AEH, Perez-Zsolt D, Muñoz-Basagoiti J, Raïch-Regué D, Izquierdo-Useros N, Rispens T, Vidarsson G, Martinez-Picado J. Resa-Infante P, et al. Biomed Pharmacother. 2024 Jun;175:116726. doi: 10.1016/j.biopha.2024.116726. Epub 2024 May 15. Biomed Pharmacother. 2024. PMID: 38754263 Free article.
Bimekizumab-bkzx.
Mitrić MM. Mitrić MM. Clin Ther. 2024 Apr;46(4):379-380. doi: 10.1016/j.clinthera.2024.03.009. Epub 2024 May 4. Clin Ther. 2024. PMID: 38705824 No abstract available.
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Patel N, Yancopoulos GD, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB; NOTUS Study Investigators. Bhatt SP, et al. N Engl J Med. 2024 Jun 27;390(24):2274-2283. doi: 10.1056/NEJMoa2401304. Epub 2024 May 20. N Engl J Med. 2024. PMID: 38767614 Clinical Trial.
Crovalimab: First Approval.
Dhillon S. Dhillon S. Drugs. 2024 Jun;84(6):707-716. doi: 10.1007/s40265-024-02032-5. Epub 2024 May 14. Drugs. 2024. PMID: 38740735 Review.
Oral Psoriasis Therapies.
James J, Otto T, Gao J, Porter ML. James J, et al. Dermatol Clin. 2024 Jul;42(3):357-363. doi: 10.1016/j.det.2024.02.013. Epub 2024 Apr 4. Dermatol Clin. 2024. PMID: 38796267 Review.
Biologics for Psoriasis.
Wride AM, Chen GF, Spaulding SL, Tkachenko E, Cohen JM. Wride AM, et al. Dermatol Clin. 2024 Jul;42(3):339-355. doi: 10.1016/j.det.2024.02.001. Epub 2024 Mar 13. Dermatol Clin. 2024. PMID: 38796266 Review.
Chronic Prurigo.
Thünemann J, Müller S, Steinbrink K, Ständer S, Zeidler C. Thünemann J, et al. J Dtsch Dermatol Ges. 2024 Jun;22(6):813-823. doi: 10.1111/ddg.15317. Epub 2024 May 9. J Dtsch Dermatol Ges. 2024. PMID: 38722190 Review.
56,297 results
You have reached the last available page of results. Please see the User Guide for more information.